13.77
13.77 (0%)
As of Jan 17, 2025
Prothena Corp Public Ltd Co [PRTA]
Source:
Company Overview
Prothena is a late-stage clinical biotechnology company with expertise in protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare peripheral amyloid diseases.
Country | Ireland |
Headquarters | dublin 2 |
Phone Number | 011-353-1-236-2500 |
Industry | manufacturing |
CEO | Gene G. Kinney |
Website | www.prothena.com |